<i>Clostridioides difficile</i> ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study
Masoumeh Azimirad, Marcela Krůtová, Abbas Yadegar, Shabnam Shahrokh, Meysam Olfatifar, Hamid Asadzadeh Aghdaei, Warren N. Fawley, Mark H. Wilcox, Mohammad Reza Zali
Abstract
-value = 0.041). Different patterns in CDI epidemiology underscore the importance of local surveillance and infection control measures in Tehran healthcare settings.
Topics & Concepts
RibotypingClostridioidesClostridium difficile toxin AToxinMicrobiologyMedicineEpidemiologyBiologyClostridium difficile toxin BInternal medicineGeneClostridium difficilePolymerase chain reactionGeneticsAntibioticsClostridium difficile and Clostridium perfringens researchMicroscopic ColitisNosocomial Infections in ICU